Treace Medical Concepts (TMCI) Stock Forecast & Price Target

$8.04 -0.25 (-3.02%)

(As of 11/12/2024 ET)

Treace Medical Concepts - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 6 Analyst Ratings

Sell
0

Hold
6

Buy
0

Based on 6 Wall Street analysts who have issued ratings for Treace Medical Concepts in the last 12 months, the stock has a consensus rating of "Hold." Out of the 6 analysts, 6 have given a hold rating for TMCI.

Consensus Price Target

$7.40
-7.96% Downside

According to the 6 analysts' twelve-month price targets for Treace Medical Concepts, the average price target is $7.40. The highest price target for TMCI is $8.00, while the lowest price target for TMCI is $6.00. The average price target represents a forecasted downside of -7.96% from the current price of $8.04.

TMCI Analyst Ratings Over Time

Type	Current Forecast 11/14/23 to 11/13/24	1 Month Ago 10/15/23 to 10/14/24	3 Months Ago 8/16/23 to 8/15/24	1 Year Ago 11/14/22 to 11/14/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	0 Buy rating(s)	0 Buy rating(s)	0 Buy rating(s)	5 Buy rating(s)
Hold	6 Hold rating(s)	6 Hold rating(s)	7 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$7.40	$7.00	$12.71	$18.92
Forecasted Upside	-7.96% Downside	34.62% Upside	112.61% Upside	159.49% Upside
Consensus Rating	Hold	Hold	Hold	Moderate Buy

625,000% Gain (Ad)

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

>> Dive into the Workshop Here

TMCI Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

TMCI Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Treace Medical Concepts Stock vs. The Competition

Type	Treace Medical Concepts	Medical Companies	S&P 500
Consensus Rating Score	2.00	2.80	2.50
Consensus Rating	Hold	Moderate Buy	Hold
Predicted Upside	-7.96% Downside	25,508.19% Upside	7.92% Upside
News Sentiment Rating	Neutral News See Recent TMCI News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
11/6/2024	Stifel Nicolaus 4 of 5 stars		Boost Target	Hold ➝ Hold	$7.00 ➝ $8.00	+5.82%
10/14/2024	Truist Financial 2 of 5 stars	R. Newitter Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Hold ➝ Hold	$7.50 ➝ $6.00	+17.42%
8/7/2024	UBS Group 4 of 5 stars		Boost Target	Neutral ➝ Neutral	$6.50 ➝ $7.00	+8.70%
7/15/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$5.50 ➝ $8.00	-1.36%
5/8/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Overweight ➝ Neutral	$15.00 ➝ $8.00	-28.06%
5/8/2024	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Zimmerman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral
The Crypto That’s Making Wall Street Sweat (Ad) The Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech giants are quietly integrating it. Venture capitalists are scrambling to invest. Click here to discover our #1 crypto for the market right now – poised for massive growth
9/12/2023	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Equal Weight ➝ Equal Weight	$25.00	+73.37%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 03:24 AM ET.

TMCI Forecast - Frequently Asked Questions

: According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for Treace Medical Concepts is $7.40, with a high forecast of $8.00 and a low forecast of $6.00.
: 6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Treace Medical Concepts in the last year. There are currently 6 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" TMCI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TMCI, but not buy additional shares or sell existing shares.
: According to analysts, Treace Medical Concepts's stock has a predicted downside of -7.96% based on their 12-month stock forecasts.
: Treace Medical Concepts has been rated by research analysts at Stifel Nicolaus, and Truist Financial in the past 90 days.
: Analysts like Treace Medical Concepts less than other "medical" companies. The consensus rating for Treace Medical Concepts is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how TMCI compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

625,000% Gain (Ad)

>> Dive into the Workshop Here

This page (NASDAQ:TMCI) was last updated on 11/13/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Treace Medical Concepts (TMCI) Stock Forecast & Price Target